106 related articles for article (PubMed ID: 884664)
1. Improvement of phytohemagglutinin responsiveness of lymphocytes from cancer patients after washing in vitro.
Mannick JA; Constantian M; Pardrige D; Saporoschetz I; Badger A
Cancer Res; 1977 Sep; 37(9):3066-70. PubMed ID: 884664
[No Abstract] [Full Text] [Related]
2. Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients.
Quan PC; Burtin P
Cancer Res; 1978 Feb; 38(2):288-96. PubMed ID: 620401
[TBL] [Abstract][Full Text] [Related]
3. Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.
Glasgow AH; Nimberg RB; Menzoian JO; Saporoschetz I; Cooperband SR; Schmid K; Mannick JA
N Engl J Med; 1974 Dec; 291(24):1263-7. PubMed ID: 4610386
[No Abstract] [Full Text] [Related]
4. [A study on the lymphocyte culture with phytohaemagglutinin from patients with leukemia and cancer].
Kimoto M
Zasshi Tokyo Ika Daigaku; 1969 Sep; 27(5):609-27. PubMed ID: 4915098
[No Abstract] [Full Text] [Related]
5. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.
Sample WF; Gertner HR; Chretien PB
J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049
[No Abstract] [Full Text] [Related]
6. The effect of phytohemagglutinin on lymphocytes from patients with renal insufficiency in in vitro cultures.
Szewczyk Z; Melcer H
Arch Immunol Ther Exp (Warsz); 1970; 18(4):460-72. PubMed ID: 5478578
[No Abstract] [Full Text] [Related]
7. In vitro behaviour of lymphocytes from cancer patients and normal individuals cultured with PHA.
Datta U; Gupta BD; Mahajan MK; Aikat BK
Indian J Cancer; 1977 Sep; 14(3):211-5. PubMed ID: 924501
[No Abstract] [Full Text] [Related]
8. Reaction of lymphocytes to phytohemagglutinin in vitro in hereditary microspherocytosis.
Polkowska-Kulesza E; Pluźaska A; Judkiewicz L
Pol Med Sci Hist Bull (1973); 1976; 15(2):221-4. PubMed ID: 959048
[TBL] [Abstract][Full Text] [Related]
9. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
[No Abstract] [Full Text] [Related]
10. [Phytohemagglutinin stimulation of lymphocytes in patients with aplastic anemia].
Haas RJ; Kretschmer V; Fliedner TM
Med Klin; 1970 Apr; 65(15):724-9. PubMed ID: 5522792
[No Abstract] [Full Text] [Related]
11. [The blood lymphocytes under the light- and electron microscope after stimulation with phytohemagglutinin. I. The effect of phytohemagglutinin on lymphocytes of healthy individuals].
Orfanos C; Pappas A; Scheurlen PG
Z Gesamte Exp Med Einschl Exp Chir; 1969; 149(4):283-93. PubMed ID: 5772874
[No Abstract] [Full Text] [Related]
12. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.
Benezra D; Hochman A
Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061
[No Abstract] [Full Text] [Related]
13. [Blastic transformation by means of phytohemagglutinin of human lymphocytes cultured in vitro in the presence of homologous plasma].
Rugarli C; Tossi B; Scorza R; Besana C; Malacco E
Haematol Lat; 1968; 11(4):367-73. PubMed ID: 5736507
[No Abstract] [Full Text] [Related]
14. Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies.
Aiuti F; Lacava V; Garofalo JA; D'Amelio R; D'Asero C
Clin Exp Immunol; 1973 Sep; 15(1):43-52. PubMed ID: 4587827
[TBL] [Abstract][Full Text] [Related]
15. Clinical immunologic responsiveness in malignant disease. II. In vitro lymphocyte response to phytohemagglutinin and the effect of cytotoxic drugs.
al-Sarraf M; Sardesai S; Vaitkevicius VK
Oncology; 1972; 26(4):357-68. PubMed ID: 5055855
[No Abstract] [Full Text] [Related]
16. [Studies on immunological responsiveness of cancer patients. I. Standardization of phytohemagglutinin-stimulated lymphocyte transformation].
Kumashiro R
Fukuoka Igaku Zasshi; 1976 Sep; 67(9):331-8. PubMed ID: 1033894
[No Abstract] [Full Text] [Related]
17. Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.
Nimberg RB; Glasgow AH; Menzoian JO; Constantian MB; Cooperband SR; Mannick JA; Schmid K
Cancer Res; 1975 Jun; 35(6):1489-94. PubMed ID: 1131820
[TBL] [Abstract][Full Text] [Related]
18. [Studies on immunological responsiveness of cancer patients. II. Phytohemagglutinin-stimulated lymphocyte transformation in patients with gastric or esophageal cancer].
Kumashiro R
Fukuoka Igaku Zasshi; 1976 Sep; 67(9):339-49. PubMed ID: 1033895
[No Abstract] [Full Text] [Related]
19. Evaluation of host immunity in human neoplasia. 1. Discussion.
Br J Cancer Suppl; 1973 Aug; 1():108-18. PubMed ID: 4804275
[No Abstract] [Full Text] [Related]
20. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease].
Eggerth G; Kühböck J; Pokorny D
Wien Z Inn Med; 1969; 50(7):314-9. PubMed ID: 5380683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
